Pharmacokinetics of Fixed-Dose Combination Tablet of Bemnifosbuvir and Ruzasvir

Clinical trial NCT06204679 · COMPLETED

Trial details

NCT number: NCT06204679
Sponsor: Atea Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer Study

Start date: 2023-12-14
Primary completion: 2024-08-25
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.